Curated News
By: NewsRamp Editorial Staff
March 24, 2026

Blood-Brain Barrier Damage Persists Decades After Contact Sports, Study Reveals

TLDR

  • Sigyn Therapeutics' CardioDialysis technology offers a potential first-mover advantage in treating neuroinflammatory diseases by clearing harmful molecules from the bloodstream.
  • CardioDialysis works by continuously purifying blood to remove inflammatory molecules, potentially stabilizing the blood-brain barrier and slowing neuroinflammatory disease progression.
  • This technology could improve quality of life for athletes and others with brain injuries by potentially slowing debilitating neuroinflammatory conditions like CTE and Alzheimer's.
  • A new study reveals contact sports can leave the brain's protective barrier leaky for decades, highlighting the need for innovative treatments like CardioDialysis.

Impact - Why it Matters

This research fundamentally changes our understanding of how contact sports affect brain health long-term, revealing that damage isn't just immediate but persists for decades. For millions of athletes, military personnel, and anyone experiencing head trauma, this means the window for intervention is much longer than previously thought. The connection between blood-brain barrier disruption and neurodegenerative diseases like Alzheimer's and Parkinson's suggests these findings could impact far beyond sports medicine. Sigyn Therapeutics' CardioDialysis technology represents a potential breakthrough approach, moving beyond symptom management to address the underlying inflammatory mechanisms driving these conditions. This could lead to preventive treatments for at-risk populations and new therapeutic options for millions suffering from neurodegenerative diseases worldwide.

Summary

In a groundbreaking development for neurological research, Trinity College Dublin scientists have reported the first clinical evidence of blood-brain barrier disruption and associated inflammation in living individuals suspected of having Chronic Traumatic Encephalopathy (CTE). This discovery, highlighted in Scientific American and published in Science Translational Medicine, reveals that the brain's protective barrier may remain compromised and permeable for decades following retirement from contact sports. The study found that former athletes exist in a persistent state of chronic hyperinflammation, with compromised blood-brain barrier integrity allowing inflammatory molecules and pathogenic toxins to enter the brain, potentially triggering abnormal tau protein accumulation characteristic of CTE.

Sigyn Therapeutics, Inc., developer of CardioDialysis™, has positioned this research as supporting evidence for their next-generation blood purification technology. The company's CardioDialysis system enables continuous broad-spectrum clearance of inflammatory and pathogenic molecules from the bloodstream, making it uniquely positioned as a potential adjunct therapy for neuroinflammatory conditions. CEO Jim Joyce emphasized that the dual reduction of inflammatory and pathogenic factors could help stabilize the blood-brain barrier and limit harmful molecule leakage into the brain. This research adds to growing evidence that systemic inflammation drives neuroinflammation associated with Alzheimer's, Parkinson's, and other neurological disorders.

While Sigyn's lead clinical indication remains cardiovascular disease treatment, the company is actively pursuing strategic applications for traumatic brain injury and neuroinflammatory conditions. The company's development pipeline includes additional technologies like ImmunePrep™ for cancer immunotherapy optimization, ChemoPrep™ for enhanced chemotherapy delivery, and ChemoPure™ for chemotherapy toxicity reduction. This research breakthrough, accessible through the original Scientific American article, represents a significant step forward in understanding CTE pathology and potential therapeutic interventions. The findings were originally released on www.newmediawire.com, highlighting the growing intersection between neurology research and innovative medical technologies.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Blood-Brain Barrier Damage Persists Decades After Contact Sports, Study Reveals

blockchain registration record for this content.